Dimethyl dioctadecyl ammonium bromide (DDA)-induced arthritis in rats: a model of experimental arthritis

Citation
Y. Mia et al., Dimethyl dioctadecyl ammonium bromide (DDA)-induced arthritis in rats: a model of experimental arthritis, J AUTOIMMUN, 14(4), 2000, pp. 303-310
Citations number
24
Categorie Soggetti
Immunology
Journal title
JOURNAL OF AUTOIMMUNITY
ISSN journal
08968411 → ACNP
Volume
14
Issue
4
Year of publication
2000
Pages
303 - 310
Database
ISI
SICI code
0896-8411(200006)14:4<303:DDAB(A>2.0.ZU;2-6
Abstract
A single intradermal injection of 2 mg of dimethyl dioctadecyl ammonium bro mide (DDA) in phosphate buffered saline (PBS) could induce polyarthritis in both LEW and DA rats with low incidence and severity whereas 2 mg of DDA i n incomplete Freund's adjuvant (IFA) could induce very severe polyarthritis with 100% incidence in LEW rats. Histology of DDA-induced arthritis (DIA) revealed cellular infiltration, synovial hypertrophy, development of granul ation tissue, destruction of cartilage and bone deformation in the articula r joints. Lymph node cells (LNCs) but not immunoglobulin fractions from the DIA rats successfully transferred the severe disease into the naive recipi ents. A challenge injection of DDA in IFA in the rats, which had recovered from the DIA, could reactivate the disease. It is thus concluded that DDA h as arthritis-inducing ability in the rats which is potentiated by IFA and t he DIA is a cell-mediated immune disease which might be a model of experime ntal arthritis. (C) 2000 Academic Press.